Business of Healthcare

Patients want quick access to health care when they need it, especially if they are ill. Urgent care centers are an accessible way to see a doctor with little or no advance notice.

Long-term care may be needed due to a chronic illness, old age, an accident or other medical issues. To pay for the cost of long-term care, one can purchase long-term care insurance.

There’s a growing trend of pharmacists being overworked, and this has been exacerbated within the last three years, even prior to the coronavirus pandemic.

Amazon's rolling out a telehealth offering to the public called Amazon Clinic, while shuttering it's in house service, Amazon Care, to enter healthcare segment.

Walmart is the latest company to announce a settlement with local governments over allegations of improperly filling prescriptions for powerful painkillers

Biopharmaceutical company Biogen has picked a new CEO, former Sanofi CEO Christopher Viehbacher, amid fallout from its failed Alzheimer's drug launch.

Walgreens will put up $3.5 billion of the $8.9 billion deal to add Summit Health-CityMD to it's primary care portfolio.

GSK reported strong third-quarter earnings and raised its forecast for 2022. However worries about Zantac litigation kept investors on edge.

Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.

J&J's cardiovascular devices business will benefit from the $16.6 billion deal to acquire Abiomed. The deal comes at a time when J&J is spinning off its consumer health business.

Open enrollment for Affordable Care Act health plans begins Tuesday, and there are a slew of changes to be aware of this year when making a selection.

Health care technology company Royal Philips NV employs roughly 80,000 employees. Philips chief executive Roy Jakobs called the job cuts "difficult, but necessary."

Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.

Novo Nordisk, which manufactures the antidiabetic drugs Ozempic and Wegovy, told FOX Business it's facing supply issues due to "unprecedented demand" on top of global supply constraints.